Fig. 1From: Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trialIncidence of treatment-emergent a dehydration and b weight loss by grade over time in the neratinib groupBack to article page